Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

A legal battle between rival developers of Covid-19 jabs over vaccine technology patents has produced a mixed ruling from a High Court judge. Pharmaceutical giant Pfizer and drug manufacturer ...

Moderna is offering to share ownership of its COVID-19 vaccine patent with the U.S. government to resolve the dispute, the vaccine maker said, and would allow the Biden administration to "license ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

As COVID vaccine patent dispute drags on, Moderna forks over $400M to NIH Moderna called the sum a "catch-up payment" for borrowing a molecular technique.

Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its Covid-19 vaccine, in a boon for the mRNA-vaccine maker in its ongoing legal fight to recoup ...

San Diego-based Allele Biotechnology and Pharmaceuticals Inc has resolved its patent dispute with Pfizer Inc and BioNTech SE over technology allegedly used in developing their COVID-19 vaccine ...

While money from Covid vaccine sales is a key driver of the dispute, the patent battle could prove influential for the development of future mRNA-based products.

The dispute was over who deserves credit for inventing the central component of the company’s Covid vaccine. Share full article Moderna lowered the heat in its vaccine patent dispute with the ...

Moderna’s COVID-19 vaccine is at the centre of a patent dispute that could potentially affect future public–private collaborations. Credit: Moch Farabi Wardana/Pacific Press/LightRocket/Getty ...